Related Experiment Video
Updated: Apr 30, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between
A M Randi1, I Rabinowitz, D J Mancuso
1Howard Hughes Medical Institute, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
Abstract:
Many variants of von Willebrand disease (vWD) with qualitatively abnormal von Willebrand factor (vWF) are recognized. In vWD type IIB, the abnormal protein displays enhanced affinity for a platelet vWF receptor, the glycoprotein Ib-IX complex. 14 patients from 7 unrelated families with vWD type IIB were studied to determine the molecular basis for this phenotype. Specific oligonucleotide primers were used to amplify portions of vWF exon 28 encoding a domain that interacts with the platelet glycoprotein Ib-IX complex. Candidate missense mutations were identified for all 14 patients by DNA sequencing, allele specific oligonucleotide hybridization, and restriction endonuclease digestion. These sequence changes occur in an 11 amino acid segment within a single disulfide loop bounded by Cys(509) and Cys(695). All of these sequence changes are C----T transitions within CG dinucleotides. Six patients from two unrelated families were heterozygous for the encoded sequence Arg(543)----Trp. Seven patients from four unrelated families were heterozygous for the encoded sequence Arg(545)----Cys; this sequence change appears to have occurred independently three times, once as a new spontaneous mutation. One patient with apparently sporadic vWD type IIB was heterozygous for the encoded sequence Val(553)----Met, and this appears to be a new mutation. None of these sequence changes was found in 100 normal alleles. These findings suggest that vWD type IIB may be caused by relatively few distinct mutations, that these mutations may cluster within a specific region of one disulfide loop in vWF domain A1, and that this region can modulate the affinity of vWF for the platelet glycoprotein Ib-IX complex.
Insights
Mutations in von Willebrand disease type IIB are linked to specific genetic changes in the von Willebrand factor (vWF). These alterations affect vWF
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Von Willebrand disease (vWD) encompasses various forms of abnormal von Willebrand factor (vWF).
- Type IIB vWD is characterized by vWF with increased affinity for platelet glycoprotein Ib-IX receptors.
Purpose of the Study:
- To investigate the molecular genetic basis of von Willebrand disease type IIB.
- To identify specific mutations responsible for the enhanced vWF-platelet interaction in vWD type IIB.
Main Methods:
- Analysis of vWF exon 28 using DNA sequencing, allele-specific oligonucleotide hybridization, and restriction endonuclease digestion.
- Studied 14 patients from 7 unrelated families with vWD type IIB.
Main Results:
- Identified missense mutations in an 11-amino acid segment within a disulfide loop of vWF domain A1.
- Common mutations included Arg(543) to Trp and Arg(545) to Cys, with some appearing as new mutations.
- All identified mutations were C-to-T transitions within CG dinucleotides.
Conclusions:
- Von Willebrand disease type IIB may result from a limited number of distinct mutations.
- These mutations are localized to a specific region within a vWF disulfide loop, modulating vWF affinity for platelet receptors.
Related Concept Videos
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

